Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoff S Higgins

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Cell Death & Disease|July 22, 2025
UPR-induced intracellular C5aR1 promotes adaptation to the hypoxic tumour microenvironmentTatsuya Suwa, Kelly Sw Lee, Ian J Chai, et al.
Cancer Research Communications|September 6, 2024
Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of ActionJames P B O'Connor, Victoria Tessyman, Ross A Little, et al.
British Journal of Cancer|October 4, 2017
IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancerTamara Aleksic, Clare Verrill, Richard J Bryant, et al.
Cancers|January 10, 2026
Outcomes Following Radiotherapy for Oligoprogressive NSCLC on Immune Checkpoint Inhibitors: A Real-World, Multinational ExperienceUmair Mahmood, Eleni Josephides, Nicholas Coupe, et al.
British Journal of Cancer|July 6, 2017
TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapyGiacomo Pirovano, Thomas M Ashton, Katharine J Herbert, et al.
Oncotarget|March 20, 2015
Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screenGaganpreet S Tiwana, Remko Prevo, Francesca M Buffa, et al.
Nature Communications|July 26, 2016
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxiaThomas M Ashton, Emmanouil Fokas, Leoni A Kunz-Schughart, et al.
Molecular Cell|December 1, 2022
POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cellsOndrej Belan, Marie Sebald, Marek Adamowicz, et al.
Cancers|April 1, 2020
External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus IncreaseTzveta D Pokrovska, Egon J Jacobus, Rathi Puliyadi, et al.
Cells|June 11, 2025
A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance-A Role for Nicotinamide N-MethyltransferaseJessica A Wright, Stephanie D White, Gavin Frame, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Cell Death & Disease|July 22, 2025
UPR-induced intracellular C5aR1 promotes adaptation to the hypoxic tumour microenvironmentTatsuya Suwa, Kelly Sw Lee, Ian J Chai, et al.
Cancer Research Communications|September 6, 2024
Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of ActionJames P B O'Connor, Victoria Tessyman, Ross A Little, et al.
British Journal of Cancer|October 4, 2017
IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancerTamara Aleksic, Clare Verrill, Richard J Bryant, et al.
Cancers|January 10, 2026
Outcomes Following Radiotherapy for Oligoprogressive NSCLC on Immune Checkpoint Inhibitors: A Real-World, Multinational ExperienceUmair Mahmood, Eleni Josephides, Nicholas Coupe, et al.
British Journal of Cancer|July 6, 2017
TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapyGiacomo Pirovano, Thomas M Ashton, Katharine J Herbert, et al.
Oncotarget|March 20, 2015
Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screenGaganpreet S Tiwana, Remko Prevo, Francesca M Buffa, et al.
Nature Communications|July 26, 2016
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxiaThomas M Ashton, Emmanouil Fokas, Leoni A Kunz-Schughart, et al.
Molecular Cell|December 1, 2022
POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cellsOndrej Belan, Marie Sebald, Marek Adamowicz, et al.
Cancers|April 1, 2020
External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus IncreaseTzveta D Pokrovska, Egon J Jacobus, Rathi Puliyadi, et al.
Cells|June 11, 2025
A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance-A Role for Nicotinamide N-MethyltransferaseJessica A Wright, Stephanie D White, Gavin Frame, et al.
Pageof 6